Connaughton Bernadette
Halozyme Therapeutics, Inc. · Director
Connaughton Bernadette is listed in public filings as director. This Connaughton Bernadette insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Halozyme Therapeutics, Inc. (HALO), and Editas Medicine Inc (EDIT). Investors use Connaughton Bernadette's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $103k1.6k shares | SellMay 1, 2026 | $63.48 | -- | |
| $141k2k shares | SellJan 5, 2026 | $70.25 | -- | |
| $59k829 shares | SellDec 1, 2025 | $71.60 | -- | |
| $137k2k shares | SellNov 10, 2025 | $68.48 | -- | |
| $113k1.5k shares | SellOct 1, 2025 | $75.09 | -- | |
| $38k500 shares | SellOct 1, 2025 | $75.70 | -- | |
| $219k3k shares | SellSep 2, 2025 | $73.62 | -- | |
| $68k923 shares | SellSep 2, 2025 | $74.11 | -- | |
| $7.2k100 shares | SellSep 2, 2025 | $71.71 | -- |